Latest Fractyl Health News & Updates

See the latest news and media coverage for Fractyl. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Fractyl Health (Fractyl)

Developer of metabolic therapies for obesity and type 2 diabetes

fractyl.com
Headquarters
Burlington, United States
Founded year
2010
Company type
Public company
Number of employees
100–200
Industry
Pharmaceuticals

Last updated

Latest news about Fractyl Health (Fractyl)

In short: Fractyl Health achieved positive clinical data for its Revita procedure and initiated its first gene therapy trial for type 2 diabetes.

Company announcements

Fractyl

Fractyl reports positive one-year Revita weight maintenance results

Patients retained ~78% of GLP-1-induced weight loss after a single procedure; 33% continued losing weight.

Unlock all announcements with a

Media coverage

Yahoo Finance

Fractyl Health (GUTS) Stock Sees Fair Value Cut As Analysts Weigh Revita Opportunity

Fractyl Health is under fresh scrutiny after analysts reset its fair value estimate from US$7.44 to US$5.03 per share, a shift that reframes expectations around...

Unlock all articles with a

Never miss news about Fractyl

Track Fractyl and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Fractyl competitors & trending companies

Browse news for competitors to Fractyl and other trending companies.